PuSH - Publication Server of Helmholtz Zentrum München

Christian, F.* ; Szaszák, M.* ; Friedl, S.* ; Drewianka, S.* ; Lorenz, D.* ; Goncalves, A.* ; Furkert, J.* ; Vargas, C.* ; Schmieder, P.* ; Götz, F.* ; Zühlke, K.* ; Moutty, M.* ; Göttert, H.* ; Joshi, M.* ; Reif, B.* ; Haase, H.* ; Morano, I.* ; Grossmann, S.* ; Klukovits, A.* ; Verli, J.* ; Gáspár, R.* ; Noack, C.* ; Bergmann, M.* ; Kass, R.* ; Hampel, K.* ; Kashin, D.* ; Genieser, H.G.* ; Herberg, F.W.* ; Willoughby, D.* ; Cooper, D.M.* ; Baillie, G.S.* ; Houslay, M.D.* ; von Kries, J.P.* ; Zimmermann, B.* ; Rosenthal, W.* ; Klussmann, E.*

Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes.

J. Biol. Chem. 286, 9079-9096 (2011)
DOI PMC
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3'-diamino-4,4'-dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMP-API-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
0.000
1.333
48
84
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2011
HGF-reported in Year 0
ISSN (print) / ISBN 0021-9258
e-ISSN 1083-351X
Quellenangaben Volume: 286, Issue: 11, Pages: 9079-9096 Article Number: , Supplement: ,
Publisher American Society for Biochemistry and Molecular Biology
Reviewing status Peer reviewed
PubMed ID 21177871
Erfassungsdatum 2011-12-31